Safety and efficacy of lenvatinib in patients with metastatic radioiodine-refractory differentiated thyroid cancer: A Russian retrospective study
Latest Information Update: 13 Oct 2020
At a glance
- Drugs Lenvatinib (Primary)
- Indications Thyroid cancer
- Focus Adverse reactions; Therapeutic Use
- 13 Oct 2020 New trial record
- 21 Sep 2020 Results presented at the 45th European Society for Medical Oncology Congress